Targeted MR Contrast Agents

  • ChemPubSoc Europe Logo
  • Author: European Journal of Inorganic Chemistry
  • Published Date: 20 March 2012
  • Source / Publisher: European Journal of Inorganic Chemistry/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Targeted MR Contrast Agents

Related Societies

Magnetic resonance imaging (MRI) is a popular non-invasive technique that enables the visualization of changes in tissues, a great help in the diagnosis of many diseases. Paramagnetic gadolinium(III) complexes are widely used to increase contrast. Relaxivity is a measure of the ability of magnetic compounds to increase the relaxation rates of the proton spins of the surrounding water molecules. This is an inherent property of imaging agents affecting the contrast, and hence the quality of the image. Relaxivity depends on the structure of the complex, the kinetics of inner-sphere and second-sphere water exchange, and the rotational dynamics of the molecule. However, these properties change when the contrast agent is bound to its target.


Peter Caravan and Zhaoda Zhang, A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, USA, summarize the efforts in their group to understand and optimize the relaxivity of contrast agents targeted to serum albumin and to fibrin (pictured). They conclude that inner-sphere water-exchange rates can be controlled by judicious use of donor groups and that the second-hydration sphere can also be tuned to augment relaxivity further. Control of rotational dynamics is a particularly powerful lever for increasing relaxivity.

The dual binder strategies described for serum albumin- and fibrin-targeted agents are generalizable to other targeted contrast agents.

Image: © Wiley-VCH


Article Views: 3540

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH